Partial federal government shutdown
HCA does not anticipate any immediate impacts to our services or disruption to provider payments at this time. We will continue to monitor the situation and share updates if anything changes.
Imaging for rhinosinusitis
Rhinosinusitis, typically referred to as sinusitis, describes a condition characterized by inflammation of the mucous membranes in the nose as well as one or more of the paranasal sinuses. Imaging does not distinguish between bacterial sinusitis and viral upper respiratory infection. Rather, the purpose of radiological imaging in acute rhinosinusitis is to confirm diagnosis in cases of recurrent acute episodes or to detect sinusitis-related complications that are suspected because of unresponsive symptoms or particular signs.
Status: Decision completed
Why is imaging for rhinosinusitis being reviewed?
Radiological imaging for evaluation of rhinosinusitis, especially chronic sinusitis, represents an area of substantial utilization in plans managed by the Washington HCA. Since imaging is insufficiently accurate to serve as the gold standard for diagnosis of rhinosinusitis, an understanding of its appropriate role is important. An evidence-based assessment of the accuracy of different imaging modalities for confirming or refining a diagnosis of rhinosinusitis and the impact on outcomes and cost is warranted to guide coverage policy.
Primary criteria ranking
- Safety = Medium
- Efficacy = High
- Cost = Medium
Documentation
| Type | Materials |
|---|---|
| Assessment (2015) |
Assessment timeline
- Draft Key Questions Published: October 6, 2014
- Public Comment Period: October 6 to 23, 2014
- Final Key Questions Published: November 19, 2014
- Draft Report Published: February 9, 2015
- Public Comment Period: February 9 to March 13, 2015
- Final Report Published: April 12, 2015
- HTCC Public Meeting: May 15, 2015